{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T02:25:12Z","timestamp":1772504712096,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ajo.2024.09.014","type":"journal-article","created":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T15:42:56Z","timestamp":1726328576000},"page":"339-345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Prevalence of Normal-Tension Glaucoma in Patients With Primary Aldosteronism"],"prefix":"10.1016","volume":"269","author":[{"given":"Kazuyuki","family":"Hirooka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9566-4587","authenticated-orcid":false,"given":"Tomomi","family":"Higashide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimikazu","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Udagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8275-6295","authenticated-orcid":false,"given":"Kenji","family":"Oki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Kometani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0012-5263","authenticated-orcid":false,"given":"Kensaku","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Akita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Kiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2024.09.014_bib0001","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","article-title":"Primary open-angle glaucoma","volume":"363","author":"Weinreb","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ajo.2024.09.014_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0079-6123(08)01101-1","article-title":"Epidemiology of primary glaucoma: prevalence, incidence, and blinding effects","volume":"173","author":"Cedrone","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.ajo.2024.09.014_bib0003","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0161-6420(92)31774-9","article-title":"Prevalence of glaucoma. The beaver dam eye study","volume":"99","author":"Klein","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.09.014_bib0004","first-page":"45","article-title":"Vision problems among seniors","volume":"16","author":"Millar","year":"2004","journal-title":"Health Rep"},{"key":"10.1016\/j.ajo.2024.09.014_bib0005","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2024.09.014_bib0006","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.survophthal.2006.02.008","article-title":"A sick eye in a sick body? Systemic findings in patients with primary open-angle glaucoma","volume":"51","author":"Pache","year":"2006","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2024.09.014_bib0007","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00061198-199712000-00007","article-title":"Physicians\u2019 guide to interactions between glaucoma and systemic medications","volume":"6","author":"Gottfredsdottir","year":"1997","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2024.09.014_bib0008","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJMra1201534","article-title":"Measuring the global burden of diseases","volume":"369","author":"Murray","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2024.09.014_bib0009","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2010.650","article-title":"US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008","volume":"303","author":"Egan","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2024.09.014_bib0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ajo.2024.09.014_bib0011","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00004872-199715010-00006","article-title":"An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and the renin-aldosterone system","volume":"15","author":"Komiya","year":"1997","journal-title":"J Hypertens"},{"key":"10.1016\/j.ajo.2024.09.014_bib0012","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.106.653964","article-title":"Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure","volume":"115","author":"Guder","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ajo.2024.09.014_bib0013","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1253\/circj.71.915","article-title":"Comparison of active renin concentration and plasma renin activity and as a prognostic predictor in patients with heart failure","volume":"71","author":"Tsutamoto","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.ajo.2024.09.014_bib0014","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1161\/CIRCULATIONAHA.106.634626","article-title":"High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction","volume":"114","author":"Beygui","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ajo.2024.09.014_bib0015","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000087842","article-title":"Renal protective effects of the renin-angiotensin-aldosterone system blockade: from evidence-based approach to perspectives","volume":"28","author":"Tylicki","year":"2005","journal-title":"Kidney Blood Press Res"},{"issue":"4","key":"10.1016\/j.ajo.2024.09.014_bib0016","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1038\/cddis.2013.240","article-title":"Aldosterone: a mediator of retinal ganglion cell death and the potential role in the pathogenesis in normal-tension glaucoma","volume":"4","author":"Nitta","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ajo.2024.09.014_bib0017","doi-asserted-by":"crossref","DOI":"10.1177\/1470320318795001","article-title":"Elevated plasma aldosterone levels are associated with a reduction in retinal ganglion cell survival","volume":"19","author":"Takasago","year":"2018","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.ajo.2024.09.014_bib0018","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Task Force Committee of Primary Aldosteronism, The Japan Endocrine Society, Guidelines for the diagnosis and treatment of primary aldosteronism\u2014the Japan Endocrine Society 2009","volume":"58","author":"Nishikawa","year":"2011","journal-title":"Endocr J"},{"key":"10.1016\/j.ajo.2024.09.014_bib0019","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-0032-1301896","article-title":"Influence of adrenal subclinical hypercortisolism on hypertension in patients with adrenal incidentaloma","volume":"120","author":"Oki","year":"2012","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ajo.2024.09.014_bib0020","unstructured":"Anderson DR, Patella VM Automated Static Perimetry. 1992nd ed. Mosby:152."},{"key":"10.1016\/j.ajo.2024.09.014_bib0021","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/APO.0000000000000177","article-title":"Update on the prevalence, etiology, diagnosis, and monitoring of normal-tension glaucoma","volume":"5","author":"Kim","year":"2016","journal-title":"Asia Pac J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.09.014_bib0022","first-page":"1641","article-title":"Tajimi Study Group, Japan Glaucoma Society, the prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study","volume":"111","author":"Iwase","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.09.014_bib0023","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1167\/iovs.08-1759","article-title":"The prevalence and types of glaucoma in Malay people: the Singapore Malay eye study","volume":"49","author":"Shen","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2024.09.014_bib0024","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajo.2018.10.017","article-title":"Prevalence of normal-tension glaucoma in the Chinese population: a systematic review and meta-analysis","volume":"199","author":"Zhao","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.09.014_bib0025","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0161-6420(92)31774-9","article-title":"Prevalence of glaucoma. The beaver dam eye study","volume":"99","author":"Klein","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.09.014_bib0026","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0161-6420(98)92665-3","article-title":"Prevalence of glaucoma and intraocular pressure distribution in a defined population. The Egna-Neumarkt study","volume":"105","author":"Bonomi","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.09.014_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108226","article-title":"Systemic hypertension as a risk factor for open-angle glaucoma: a meta-analysis of population-based studies","volume":"9","author":"Bae","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2024.09.014_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285039","article-title":"Blood flow in the optic nerve head in patients with primary aldosteronism","volume":"18","author":"Hirooka","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2024.09.014_bib0029","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/02713683.2022.2029907","article-title":"Compromised blood flow in the optic nerve head after systemic administration of aldosterone in rats: a possible rat model of retinal ganglion cell loss","volume":"47","author":"Wada","year":"2022","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ajo.2024.09.014_bib0030","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1167\/iovs.11-9167","article-title":"Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels","volume":"53","author":"Fujita","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2024.09.014_bib0031","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1167\/iovs.04-0490","article-title":"Caspase-independent component of retinal ganglion cell death, in vitro","volume":"45","author":"Tezel","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2024.09.014_bib0032","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11883-017-0678-6","article-title":"Oxidative stress in atherosclerosis","volume":"19","author":"Kattoor","year":"2017","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ajo.2024.09.014_bib0033","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.3390\/ijms23094803","article-title":"Primary aldosteronism and resistant hypertension: a pathophysiological insight","volume":"23","author":"Bioletto","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajo.2024.09.014_bib0034","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2471\/BLT.13.121954","article-title":"Control of hypertension with medicine: a comparative analysis of national survey in 20 countries","volume":"92","author":"Ikeda","year":"2014","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ajo.2024.09.014_bib0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev-med-042921-100438","article-title":"Primary aldosteronism and the role of mineralocorticoid receptor antagonists for the heart and kidneys","volume":"74","author":"Cohen","year":"2023","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ajo.2024.09.014_bib0036","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0161-6420(99)00525-4","article-title":"High prevalence of glaucoma in patients with sleep apnea syndrome","volume":"106","author":"Mojon","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.09.014_bib0037","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.ijg.0000243472.51461.24","article-title":"Prevalence of normal tension glaucoma in obstructive sleep apnea syndrome patients","volume":"16","author":"Sargi","year":"2007","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2024.09.014_bib0038","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00417-007-0656-8","article-title":"Ocular blood flow in patients with obstructive sleep apnea syndrome (OSAS)","volume":"246","author":"Karakucuk","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2024.09.014_bib0039","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/IJG.0b013e3181f3eb81","article-title":"Normal tension glaucoma in patients with obstructive sleep apnea\/hypopnea syndrome","volume":"20","author":"Lin","year":"2011","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2024.09.014_bib0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/IJG.0000000000001964","article-title":"Multiple systemic vascular risk factors are associated with low-tension glaucoma","volume":"31","author":"Funk","year":"2022","journal-title":"J Glaucoma"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424004343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424004343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T22:21:51Z","timestamp":1738621311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939424004343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":40,"alternative-id":["S0002939424004343"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2024.09.014","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of Normal-Tension Glaucoma in Patients With Primary Aldosteronism","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2024.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}